Titre : | Synthetic cannabinoid induced psychosis in a previously nonpsychotic patient (2012) |
Auteurs : | S. PEGLOW ; J. BUCHNER ; G. BRISCOE |
Type de document : | Article : Périodique |
Dans : | American Journal on Addictions (Vol.21, n°3, May-June 2012) |
Article en page(s) : | 287-288 |
Langues: | Anglais |
Discipline : | PSY (Psychopathologie / Psychopathology) |
Mots-clés : |
Thésaurus mots-clés TROUBLE BIPOLAIRE ; ETUDE DE CAS ; CANNABINOIDES ; DROGUES DE SYNTHESE ; PSYCHOSEThésaurus géographique ETATS-UNIS |
Résumé : | Synthetic cannabinoids are relatively new substances that have become rapidly popular among young adults. Despite their legal status in most states, they are virtually unregulated and unstudied. Nevertheless, recent case studies have brought new attention to their potentially harmful side effects, such as psychosis, agitation, and withdrawal. This case report examines the acute psychosis displayed by a psychiatric patient after smoking "Spice," a substance comprised of various synthetic cannabinoids, on three separate occasions. Furthermore, in comparing this patient's lack of psychotic symptoms after tetrahydrocannabinol (THC) use, to the episodes of psychosis experienced after "Spice" consumption this case study explores the possibility that synthetic cannabinoids are more potent than their organic counterpart. This is the first case report of synthetic cannabinoid-induced psychosis in a previously nonpsychotic patient. [Extract] |
Domaine : | Drogues illicites / Illicit drugs |
Sous-type de document : | Etude de cas / Case report |
Refs biblio. : | 9 |
Affiliation : | Department of Psychiatry and Behavioral Medicine, Eastern Virginia Medical School, Norfolk, Virginia Department of Psychiatry, Hampton Veterans Affairs Medical Center, Hampton, Virginia, USA |
Accueil